Log in to save to my catalogue

Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways

Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6566851

Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways

About this item

Full title

Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways

Publisher

Switzerland: MDPI AG

Journal title

Nutrients, 2019-05, Vol.11 (5), p.1026

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The intestinal microbiota is well known to have multiple benefits on human health, including cancer prevention and treatment. The effects are partially mediated by microbiota-produced short chain fatty acids (SCFAs) such as butyrate, propionate and acetate. The anti-cancer effect of butyrate has been demonstrated in cancer cell cultures and animal...

Alternative Titles

Full title

Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6566851

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6566851

Other Identifiers

ISSN

2072-6643

E-ISSN

2072-6643

DOI

10.3390/nu11051026

How to access this item